Trademark: NEUVAX
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for NEUVAX
We do not have any records of a proof of use for NEUVAX at this moment.
Possible trademark infringements of NEUVAX
Basic Information about NEUVAX
- Serial Number
- 87878311
- Filing Date
- 16 Apr 2018
- Registration Number
- 6622822
- Registration Date
- 18 Jan 2022
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of NEUVAX on the blockchain with WikiTrademarks.io.
- First use of NEUVAX anywhere
- NEUVAX was first used on 31 Dec 2015 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
Who owns NEUVAX?
1. SELLAS Life Sciences Group, Inc. New York NY
2. SELLAS Life Sciences Group, Inc. New York NY
3. SELLAS Life Sciences Group, Inc. New York NY
Correspondent
- Neil C. Jones
- NELSON MULLINS RILEY & SCARBOROUGH LLP
- 301 South College Street
- Suite 2300, IP Department
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io